Showing results (321-330 of 606) with videos related to

Sort By:
Pageof 61
European Journal of Drug Metabolism and Pharmacokinetics|September 10, 2008
Pharmacokinetics of YK754, a novel If channel inhibitor in rats, dogs and humansK-I Umehara, T Nakamata, K Suzuki, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 19, 2008
Tissue distribution of YM758, a novel If channel inhibitor, in pregnant and lactating ratsK-I Umehara, K Seya, T Iwatsubo, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 16, 2005
Identification of metabolites of [14C]zonampanel, an a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, following intravenous infusion in healthy volunteersT Minematsu, K-Y Sohda, T Hashimoto, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Biological properties of ME2303 (FAD-104), a new anthracyclineS Omoto, S Kondo, S Fukatsu, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Report of nationwide questionnaire: intraperitoneal chemotherapy for advanced ovarian cancer based on clinical results--reports of 5th "Gynecologic Intraperitoneal Chemotherapy Study Group" meeting]S Umezawa, Y Shimizu, K Takizawa, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 1, 1989
Heterogeneity of big-big hPRL in hyperprolactinemiaT Tanaka, H Yano, S Umezawa, et al.
Acta Paediatrica Scandinavica. Supplement|January 1, 1987
An attempt to assess the replacement dose of human growth hormone in the treatment of growth hormone deficient childrenI Hibi, T Tanaka, H Yano, et al.
Nihon Sanka Fujinka Gakkai Zasshi|November 1, 1993
[Studies on the point mutation of ras oncogene in ovarian tumor]I Fujimoto, Y Shimizu, S Umezawa, et al.
Endocrinologia Japonica|February 1, 1989
Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assayY Ohmae, H Yano, S Umezawa, et al.
Oncology Reports|May 19, 2011
Activity of cytotoxic agents against clear cell carcinoma of the ovary which is intrinsically platinum-refractoryY Shimizu, H Nagata, S Umezawa, et al.
Pageof 61